Ovarian cancer : new research / A.P. Bardos, editor.

Format:

Book

Contributor:

Bardos, A. P.

Series:

Horizons in cancer research ; v. 19.

Horizons in cancer research series ; v. 19

Language:

English

Subjects (All):

Ovaries--Cancer.

Ovaries.

Physical Description:

1 online resource (313 p.)

Edition:

1st ed.

Place of Publication:

New York : Nova Biomedical Books, 2009.

Language Note:

English

Summary:

This new volume presents the latest research on therapies for ovarian cancer. Ovarian cancer is cancer that begins in the cells that constitute the ovaries, including surface epithelial cells, germ cells, and the sex cord-stromal cells. Cancer cells that metastasize from other organ sites to the ovary (most commonly breast or colon cancers) are not then considered ovarian cancer. According to the American Cancer Society, ovarian cancer accounts for 4 percent of all cancers among women and ranks fifth as a cause of their deaths from cancer. The American Cancer Society statistics for ovarian cancer estimate that there will be 25,400 new cases and 14,300 deaths in 2003. The death rate for this disease has not changed much in the last 50 years. Unfortunately, almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is at an advanced stage--i.e., has spread to the upper abdomen (stage III) or beyond (stage IV). The 5-year survival rate for these women is only 15 to 20 percent, whereas the 5-year survival rate for stage I disease patients approaches 90 percent and for stage II disease patients approaches 70 percent.

Contents:

ch. 1. Progress in ovarian cancer research / Dilek Aktas

ch. 2. Ovulation and ovarian surface epithelial cancer / William J. Murdoch and Anna C. McDonnel

ch. 3. Ovarian sertoli-leydig cell tumors with heterologous elements / Evanthia Kostopoulou and Alexander Talerman

ch. 4. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer / G. Hudelist ... [et al.]

ch. 5. Role of membrane-associated serine/threonine phosphatase in ovarian cancer cell survival : evidence for minor role of apoptosis in gonadotropin-releasing hormone's antiproliferative signaling / Atsushi Imai ... [et al.]

ch. 6. Docetaxel in combination with carboplatin as first-line chemotherapy for patients with epithelial ovarian cancer / Yoichi Aoki and Kenichi Tanaka

ch. 7. Immunospecific albumin microspheres as delivery system for cisplatin and 5-fluorouracil for the treatment of ovarian adenocarcinoma / Ernest J. Truter and Aldina S. Santos

ch. 8. Strategies for improving outcome in ovarian cancer : the role of surgery / Karsten Münstedt ... [et al.]

ch. 9. Should systematic lymphadenectomy be performed in suboptimally debulked patients with stage III ovarian carcinoma? : a Degog study / Ugar Syagili ... [et al.]

ch. 10. Outcomes for surgery in ovarian cancer / L. Elit

ch. 11. Do ascites, mass volume and peritoneal carcinomatosis affect serum CA-125 levels in patients with ovarian carcinoma? : a different point of view / Ugar Saygili ... [et al.]

ch. 12. The usefulness of serum CA-125 levels in the prediction of optimal primary cytoreduction in patients with advanced ovarian carcinoma / Ugar Syagili, Serkan Guclu and Oktay Erten

ch. 13. Perceived risk of ovarian cancer, worry about ovarian cancer risk, and use of ovarian cancer screening by women at risk for ovarian cancer / M. Robyn Andersen ... [et al.]

ch. 14. New strategy for the treatment of ovarian cancer with the aim to conquer chemoresistance / Junzo Kigawa ... [et al.]

ch. 15. Treatment decision making in ovarian cancer / L. Elit.

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

Description based on print version record.

ISBN:

1-60876-695-0

OCLC:

923667943